Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Hedgehog signaling is essential for normal sebaceous gland development and affects keratin 6a expression.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Certain RNA molecules are important for the development of wool follicles in sheep.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Oral testosterone therapy raises heart risk more than other methods.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

A new method accurately measures nine specific hormones in human blood.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.